MedTrace Logo

Efficacy of a Probiotic Strain on Level of Markers of Inflammation in an Elderly Population

NCT05529693 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2023-12-04

No results posted yet for this study

Summary

To investigate the effectiveness of two doses of the probiotic strain Bif-038 on markers of low-grade inflammation in a elderly population

Conditions

Interventions

DIETARY_SUPPLEMENT

Experimental: Bif-038 arm, high dose

Active trial product with minimum 10 billion CFU daily dose

DIETARY_SUPPLEMENT

Experimental: Bif-038 arm, low dose

Active trial product with minimum 1 billion CFU daily dose

DIETARY_SUPPLEMENT

Placebo Comparator: Placebo arm

Similar product to trial product but without Bif-038

Sponsors & Collaborators

  • Chr Hansen

    lead INDUSTRY

Principal Investigators

  • Timothy Dinan, Professor · Atlantia Clinical Trials

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-29
Primary Completion
2023-11-30
Completion
2023-12-01

Countries

  • Ireland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05529693 on ClinicalTrials.gov